Association of British Clinical Diabetologists

Degludec Nationwide Audit

 
Home Live ABCD nationwide audits of new therapies All ABCD nationwide audits Future audits of new therapies ABCD worldwide audits
     

Above - scene from an animation explaining the mode of action of insulin degludec - click to see Powerpoint slide show
 

Above: In clinical trials there was considerably less intra-subject variability with degludec than with glargine. Potentially therefore patients with very variable patterns of home blood glucose monitoring may benefit from a switch to degludec – click to enlarge
 

Above: In clinical trials degludec was associated with less hypoglycaemia than other insulins and allowed for flexible dosing. The audit may give insight into whether these potential advantages translate in real clinical practice - click to enlarge
 

ABCD nationwide insulin degludec audit

 Papers, abstracts, presentations, posters and webcasts emanating from the audit

Webcast

EASD Lisbon 2017: AN Lumb, RD Rea, RR Abraham, P Macdonald, SC Bain, REJ Ryder on behalf of the ABCD nationwide degludec audit contributors.  Effect of insulin degludec on HbA1c, weight and hypoglycaemia: data from the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit

 

Abstracts
ABCD Spring Meeting, London 2016: A Lumb, R Abraham, R Harper, SC Bain, R Rea, REJ Ryder, on behalf of the ABCD nationwide degludec audit contributors. Insulin degludec improves minor, severe and nocturnal hypoglycaemia in Type 1 diabetes: Association of British Clinical Diabetologists (ABCD) nationwide insulin degludec audit.

 

DUK Manchester 2017: AN Lumb, RD Rea, R Abraham, P McDonald, SC Bain and REJ Ryder. Effect on HbA1c of switching to insulin degludec from another basal insulin: the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit. Diabetic Medicine 2017. 34 (Suppl 1): Abstract P182

 

EASD Lisbon 2017: AN Lumb, RD Rea, RR Abraham, P Macdonald, SC Bain, REJ Ryder on behalf of the ABCD nationwide degludec audit contributors. Effect of insulin degludec on HbA1c, weight and hypoglycaemia: data from the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit. Diabetologia 2017, Vol.60 Supplement1: Abstract 669

 

ADA Orlando 2018: AN. Lumb, Ian W. Gallen, A Bickerton, RR. Abraham, SC. Bain, R Harper, RE Ryder and ABCD Nationwide Degludec Audit Contributors. Use of Insulin Degludec in Type 1 Diabetes Clinical Practice in the U.K.—General Practice Data from Two English Regions and Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Degludec Audit. Diabetes 2018 Jul; 67 (Supplement 1): 2291-PUB. 



Posters
ABCD Manchester, Spring 2016

EASD Lisbon 2017

    Register for the audit

Access the on-line tool

Degludec audit objectives

Order preprinted data entry forms

Download first visit data entry form

Download follow up visit data entry form

Further information- contact us

Main ABCD homepage

     

The ABCD nationwide insulin degludec audit is an independent audit supported by an unrestricted grant from Novo Nordisk

Working to support high quality diabetes care in the UK